Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors
Neurofibroma/schwannoma hybrid nerve sheath tumors (N/S HNSTs) are neoplasms associated with larger nerves that occur sporadically and in the context of schwannomatosis or neurofibromatosis type 2 or 1. Clinical management of N/S HNST is challenging, especially for large tumors, and established syst...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 4, 2020
|
| In: |
The journal of clinical investigation
Year: 2020, Volume: 130, Issue: 5, Pages: 2488-2495 |
| ISSN: | 1558-8238 |
| DOI: | 10.1172/JCI130787 |
| Online Access: | Resolving-System, Volltext: https://doi.org/10.1172/JCI130787 Verlag: https://www.jci.org/articles/view/130787 |
| Author Notes: | Michael W. Ronellenfitsch, Patrick N. Harter, Martina Kirchner, Christoph Heining, Barbara Hutter, Laura Gieldon, Jens Schittenhelm, Martin U. Schuhmann, Marcos Tatagiba, Gerhard Marquardt, Marlies Wagner, Volker Endris, Christian H. Brandts, Victor-Felix Mautner, Evelin Schröck, Wilko Weichert, Benedikt Brors, Andreas von Deimling, Michel Mittelbronn, Joachim P. Steinbach, David E. Reuss, Hanno Glimm, Albrecht Stenzinger, and Stefan Fröhling |
| Summary: | Neurofibroma/schwannoma hybrid nerve sheath tumors (N/S HNSTs) are neoplasms associated with larger nerves that occur sporadically and in the context of schwannomatosis or neurofibromatosis type 2 or 1. Clinical management of N/S HNST is challenging, especially for large tumors, and established systemic treatments are lacking. |
|---|---|
| Item Description: | First published February 4, 2020 Gesehen am 02.032020 |
| Physical Description: | Online Resource |
| ISSN: | 1558-8238 |
| DOI: | 10.1172/JCI130787 |